Laurus Labs Limited Total Assets
Laurus Labs Limited total assets. Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) holds total assets worth Rs105.11 Billion INR (≈ $1.14 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Laurus Labs Limited (LAURUSLABS) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Laurus Labs Limited (2013–2026)
Total assets of Laurus Labs Limited from 2013 to 2026. This chart illustrates how Laurus Labs Limited's total assets have evolved over time, based on quarterly financial data. See Laurus Labs Limited share price for real-time trading data and today's change.
Laurus Labs Limited - Asset Composition Analysis
Laurus Labs Limited Total Assets Breakdown (March 2026)
Laurus Labs Limited total assets breakdown as of March 2026. Laurus Labs Limited's total assets of Rs105.11 Billion consist of 45.9% current assets and 54.1% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 1.1% |
| Accounts Receivable | Rs21.56 Billion | 20.5% |
| Inventory | Rs23.42 Billion | 22.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs184.00 Million | 0.2% |
| Goodwill | Rs2.46 Billion | 2.3% |
Asset Composition Trend (2013–2026)
This chart illustrates how Laurus Labs Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Laurus Labs Limited's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laurus Labs Limited's current assets represent 45.9% of total assets in 2026, a decrease from 47.0% in 2013.
- Cash Position: Cash and equivalents constituted 1.1% of total assets in 2026, up from 0.4% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 22.3% of total assets.
Laurus Labs Limited Competitors by Total Assets
Key competitors of Laurus Labs Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥11.59 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
China | CN¥10.37 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
Laurus Labs Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.13 | 1.25 |
| Quick Ratio | 0.68 | 0.64 | 0.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs11.94 Billion | Rs4.67 Billion | Rs6.18 Billion |
Laurus Labs Limited - Advanced Valuation Insights
This section examines the relationship between Laurus Labs Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 20.07 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 12.6% |
| Total Assets | Rs105.11 Billion |
| Market Capitalization | $13.72 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Laurus Labs Limited's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Laurus Labs Limited's assets grew by 12.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Laurus Labs Limited (2013–2026)
The table below shows the annual total assets of Laurus Labs Limited from 2013 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs105.11 Billion ≈ $1.14 Billion |
+12.59% |
| 2025-03-31 | Rs93.36 Billion ≈ $1.01 Billion |
+11.31% |
| 2024-03-31 | Rs83.87 Billion ≈ $907.03 Million |
+9.49% |
| 2023-03-31 | Rs76.60 Billion ≈ $828.44 Million |
+9.94% |
| 2022-03-31 | Rs69.68 Billion ≈ $753.57 Million |
+21.17% |
| 2021-03-31 | Rs57.51 Billion ≈ $621.92 Million |
+53.34% |
| 2020-03-31 | Rs37.50 Billion ≈ $405.58 Million |
+12.58% |
| 2019-03-31 | Rs33.31 Billion ≈ $360.26 Million |
+10.42% |
| 2018-03-31 | Rs30.17 Billion ≈ $326.25 Million |
+13.69% |
| 2017-03-31 | Rs26.53 Billion ≈ $286.96 Million |
+15.21% |
| 2016-03-31 | Rs23.03 Billion ≈ $249.07 Million |
+24.98% |
| 2015-03-31 | Rs18.43 Billion ≈ $199.28 Million |
+44.73% |
| 2014-03-31 | Rs12.73 Billion ≈ $137.69 Million |
+80.98% |
| 2013-03-31 | Rs7.03 Billion ≈ $76.08 Million |
-- |
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal… Read more